Page last updated: 2024-09-02
testosterone 17-glucosiduronate and Substance-Related Disorders
testosterone 17-glucosiduronate has been researched along with Substance-Related Disorders in 2 studies
Research
Studies (2)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Bowers, LD | 1 |
Ekström, L; Garle, M; Lundmark, J; Rane, A; Schulze, JJ; Skilving, I | 1 |
Other Studies
2 other study(ies) available for testosterone 17-glucosiduronate and Substance-Related Disorders
Article | Year |
---|---|
Testosterone doping: dealing with genetic differences in metabolism and excretion.
Topics: Doping in Sports; Epitestosterone; Gas Chromatography-Mass Spectrometry; Genotype; Glucuronosyltransferase; Humans; Male; Minor Histocompatibility Antigens; Reference Values; Substance-Related Disorders; Testosterone | 2008 |
Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation.
Topics: Adolescent; Adult; Doping in Sports; Epitestosterone; Gas Chromatography-Mass Spectrometry; Gene Dosage; Genotype; Glucuronosyltransferase; Humans; Male; Middle Aged; Minor Histocompatibility Antigens; Sensitivity and Specificity; Substance-Related Disorders; Testosterone | 2008 |